Generating fit-for-purpose real-world evidence in Asia: How far are we from closing the gaps?
Evidence generated by randomized controlled trials (RCTs) does not often represent the patient journey and clinical outcomes in the real world due to limited external validity or generalizability. Studies based on real-world data are intended to generalize results to the broader population; however,...
Main Authors: | Wen-Yi Shau, Sajita Setia, Salil Shinde, Handoko Santoso, Daniel Furtner |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Perspectives in Clinical Research |
Subjects: | |
Online Access: | http://www.picronline.org/article.asp?issn=2229-3485;year=2023;volume=14;issue=3;spage=108;epage=113;aulast=Shau |
Similar Items
-
Real World Research: Bridging the Gap Between Clinical Practice Guidelines and Clinical Decision Making
by: SHI Xiuqing, et al.
Published: (2023-07-01) -
Editorial: The use of real world data for regulatory purposes in the rare diseases setting
by: Viviana Giannuzzi, et al.
Published: (2022-11-01) -
Real-world evidence for regulatory decision-making: updated guidance from around the world
by: Leah Burns, et al.
Published: (2023-10-01) -
Worldwide Trends in Registering Real-World Studies at ClinicalTrials.gov: A Cross-Sectional Analysis
by: Li Y, et al.
Published: (2023-03-01) -
A blueprint for success in real-world evidence: “glocal” approach to building capabilities and generating impactful evidence
by: Kristoffer Larsen, et al.
Published: (2023-10-01)